| abstract |
(For example, through the inhibition of one or more members of the p38 mitogen-activated protein kinase enzymes, Syk kinase, and members of the Src family of tyrosine kinases), and in particular inflammatory lung, There is provided a compound of formula < RTI ID = 0.0 > (I) < / RTI > having utility in therapeutic agents, including pharmaceutical combinations, Wherein R, R 1 , R a , R b , Q, X and Y have the meanings given in the specification. |